Features
Preemption and Generic Drug Liability
Recent cases attempt to further explain courts' interpretations of preemption principles in the context of generic drug labeling and liability. It is further evidence that each case is fact-based, and the final chapter in this area likely has not yet been written.
Features
Practice Tip: Constitutional Standing, Numerosity, and the Beer Drinker's Burden
The first part of this article explained the background behind lawsuits alleging that Anheuser-Busch InBev is "watering down" its beer, and that consumers can purportedly bring a class action against the company in federal court. The discussion concludes herein.
Recent Developments Since <i>Pliva v. Mensing</i>
In <I>PLIVA v. Mensing</I>, a 5-4 majority of the Supreme Court held that federal regulations applicable to generic pharmaceuticals preempt state law claims alleging that the manufacturers failed to warn consumers of the drug's risks.
Columns & Departments
Real Property Law
A look at several important rulings.
Columns & Departments
Landlord & Tenant
A look at several recent rulings.
Columns & Departments
Development
Discussion of a case about good-faith reliance.
Columns & Departments
Cooperatives & Condominiums
Discussion of a recent important ruling.
Features
Second Circuit Construes ILSA to Rescue Condominium Purchasers
Does ILSA, which permits a buyer to rescind a purchase if the buyer has not received a statutorily mandated "printed property report," apply to single-floor condominium units?
Columns & Departments
Decisions of Interest
In-depth analysis of a recent key case.
Columns & Departments
NJ & CT News
What's going on in neighboring states.
Need Help?
- Prefer an IP authenticated environment? Request a transition or call 800-756-8993.
- Need other assistance? email Customer Service or call 1-877-256-2472.
MOST POPULAR STORIES
- Law Firms and the Rise of HospitalityThe law firm office cannot remain unchanged, as if frozen in time set to some date prior to the onset of pandemic, when the terms and meaning have all changed. In fact, the office must now provide benefits or an experience the lawyers and staff cannot get at home.Read More ›
- The DOJ's Corporate Enforcement Policy: One Year LaterThe DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.Read More ›
- From the PTO to the FDA: What to Consider When Branding Clinical TrialsThe legal implications of branding generally arise initially for companies during the process of selecting a company name and any initial product or service names. For drug development companies, however, careful consideration should also be paid to the implications of branding a clinical trial.Read More ›
- Disconnect Between In-House and Outside Counsel'Disconnect Between In-House and Outside Counsel is a continuation of the discussion of client expectations and the disconnect that often occurs. And although the outside attorneys should be pursuing how inside-counsel actually think, inside counsel should make an effort to impart this information without waiting to be asked.Read More ›